| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 113, 1191-1196, Copyright © 1983 by Endocrine Society
ARTICLES |
CB Webb, M Szabo and LA Frohman
Glucocorticoids and estrogens each affect GH secretion in vivo. The effects of corticosterone and estradiol (E2) were studied singly and in combination on GH secretion and cell content of primary cultures of rat adenohypophyseal cells grown in media containing intact or hormone- deficient serum. Secretion was measured under basal conditions and in response to maximally stimulatory doses of ectopic GH-releasing factor (E-GHRF) derived from a carcinoid tumor and dibutyryl cAMP [(DBcAMP) 10(-3) M]. Basal GH release measured over a 4-h period was suppressed by 40% (P less than 0.001) when hormone-deficient serum was substituted for normal serum in the growth media, and the stimulatory responses to DBcAMP and E-GHRF were markedly attenuated (P less than 0.001). The GH content of unstimulated cells was also decreased [29 +/- (SE) 7%, P less than 0.001]. The addition of corticosterone, 3 X 10(-8) M to 3 X 10(-6) M, to the 4-day growth media resulted in dose-related increases in basal and DBcAMP-stimulated GH release during the 4-h test period which was proportional to the increases in total cellular GH content. In contrast, corticosterone exposure caused a dose-related enhancement of E-GHRF-stimulated release above that accounted for by the increase in total GH content alone. Concomitant exposure to the releasing stimuli and corticosterone during a 4-h incubation, however, reduced the effects of the releasing stimuli. The addition of E2, 10(-10) M to 10(-8) M, during the 4-day growth period and/or the 4-h stimulation period did not affect the secretion of GH either basally or in response to the stimuli. E2 did increase the cell content of GH, but the effects were not additive to those of corticosterone. These studies indicate that long term (4-day) exposure to corticosterone increases net GH synthesis and E-GHRF-stimulated release, but that acute (4 h) exposure inhibits stimulated release. Although E2 also increases cellular content of GH, it exhibits no demonstrable direct effects on GH secretion or content in the presence of corticosterone.
This article has been cited by other articles:
![]() |
G. V. Childs, M. Iruthayanathan, N. Akhter, G. Unabia, and B. Whitehead-Johnson Bipotential Effects of Estrogen on Growth Hormone Synthesis and Storage in Vitro Endocrinology, April 1, 2005; 146(4): 1780 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. McDuffie, N. Akhter, and G. V. Childs Regulation of Leptin mRNA and Protein Expression in Pituitary Somatotropes J. Histochem. Cytochem., February 1, 2004; 52(2): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gusenoff, S. M. Harman, J. D. Veldhuis, J. J. Jayme, C. St. Clair, T. Munzer, C. Christmas, K. G. O'Connor, T. E. Stevens, M. F. Bellantoni, et al. Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E616 - E625. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Dean and T. E. Porter Regulation of Somatotroph Differentiation and Growth Hormone (GH) Secretion by Corticosterone and GH-Releasing Hormone during Embryonic Development Endocrinology, March 1, 1999; 140(3): 1104 - 1110. [Abstract] [Full Text] |
||||
![]() |
V. A. Dipippo and C. A. Powers Tamoxifen and ICI 182,780 Interactions with Thyroid Hormone in the Ovariectomized-Thyroidectomized Rat J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 142 - 148. [Abstract] [Full Text] |
||||
![]() |
J. Jansson, T. Downs, W. Beamer, and L. Frohman Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice Science, April 25, 1986; 232(4749): 511 - 512. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |